Cargando…
Cancer Biomarkers: Are We Ready for the Prime Time?
A biomarker is a characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. In cancer, a biomarker refers to a substance or process that is indicative of the presence of cance...
Autores principales: | Mishra, Alok, Verma, Mukesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827599/ https://www.ncbi.nlm.nih.gov/pubmed/24281040 http://dx.doi.org/10.3390/cancers2010190 |
Ejemplares similares
-
Immunotherapy for Cervical Cancer: Are We Ready for Prime Time?
por: Turinetto, Margherita, et al.
Publicado: (2022) -
Complement in Sickle Cell Disease: Are We Ready for Prime Time?
por: Varelas, Christos, et al.
Publicado: (2021) -
Liquid biopsies, are we ready for prime time?
por: Normanno, Nicola, et al.
Publicado: (2023) -
Kidney Xenotransplantation: Are We Ready for Prime Time?
por: dos Santos, Rafael Miyashiro Nunes
Publicado: (2023) -
Endoscopic ultrasound-guided gastroenterostomy: Are we ready for prime time?
por: Rimbaş, Mihai, et al.
Publicado: (2017)